Risk Analysis Index and 30-Day Mortality after Brain Tumor Resection: A Multicenter Frailty Analysis of 31,776 Patients from 2012 to 2020

Abstract

Introduction The aim of this study was to evaluate the discriminative accuracy of the preoperative Risk Analysis Index (RAI) frailty score for prediction of mortality or transition to hospice within 30 days of brain tumor resection (BTR) in a large multicenter, international, prospective database.

Methods Records of BTR patients were extracted from the American College of Surgeons National Surgical Quality Improvement Program (2012–2020) database. The relationship between the RAI frailty scale and the primary end point (mortality or discharge to hospice within 30 days of surgery) was assessed using linear-by-linear proportional trend tests, logistic regression, and receiver operating characteristic (ROC) curve analysis (area under the curve as C-statistic).

Results Patients with BTR (N = 31,776) were stratified by RAI frailty tier: 16,800 robust (52.8%), 7,646 normal (24.1%), 6,593 frail (20.7%), and 737 severely frail (2.3%). The mortality/hospice rate was 2.5% (n = 803) and was positively associated with increasing RAI tier: robust (0.9%), normal (3.3%), frail (4.6%), and severely frail (14.2%) (p < 0.001). Isolated RAI was a robust discriminatory of primary end point in ROC curve analysis in the overall BTR cohort (C-statistic: 0.74; 95% confidence interval [CI]: 0.72–0.76) as well as the malignant (C-statistic: 0.74; 95% CI: 0. 67–0.80) and benign (C-statistic: 0.71; 95% CI: 0.70–0.73) tumor subsets (all p < 0.001). RAI score had statistically significantly better performance compared with the 5-factor modified frailty index and chronological age (both p < 0.0001).

Conclusions RAI frailty score predicts 30-day mortality after BTR and may be translated to the bedside with a user-friendly calculator (https://nsgyfrailtyoutcomeslab.shinyapps.io/braintumormortalityRAIcalc/). The findings hope to augment the informed consent and surgical decision-making process in this patient population and provide an example for future study designs.

Keywords

frailty - Risk Analysis Index - brain Tumor - neuro-oncology - National Surgical Quality Improvement Program

Publication History

Received: 12 November 2022

Accepted: 12 January 2023

Accepted Manuscript online:
18 January 2023

Article published online:
13 February 2023

• References

• 1 Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 2006; 20 (04) E1
• 2 Pazniokas J, Gandhi C, Theriault B. et al. The immense heterogeneity of frailty in neurosurgery: a systematic literature review. Neurosurg Rev 2021; 44 (01) 189-201
• 3 Arya S, Varley P, Youk A. et al. Recalibration and external validation of the risk analysis index: a surgical frailty assessment tool. Ann Surg 2020; 272 (06) 996-1005
• 4 Hall DE, Arya S, Schmid KK. et al. Development and initial validation of the risk analysis index for measuring frailty in surgical populations. JAMA Surg 2017; 152 (02) 175-182
• 5 Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. John Wiley & Sons; 2013
• 6 R. The R Project for Statistical Computing. . Accessed August 21, 2022 at: https://www.r-project.org/
• 7 Harrell Jr FE. . rms: Regression Modeling Strategies. Accessed August 21, 2022 at: https://CRAN.R-project.org/package=rms
• 8 Chang W, Cheng J, Allaire JJ. , et al. shiny: Web Application Framework for R. Accessed August 21, 2022 at: https://CRAN.R-project.org/package=shiny
• 9 Thommen R, Kazim SF, Rumalla K. et al. Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis. J Neurooncol 2022; 160 (02) 285-297
• 10 Sastry RA, Pertsch NJ, Tang O, Shao B, Toms SA, Weil RJ. Frailty and outcomes after craniotomy for brain tumor. J Clin Neurosci 2020; 81: 95-100
• 11 Dicpinigaitis AJ, Hanft S, Cooper JB. et al. Comparative associations of baseline frailty status and age with postoperative mortality and duration of hospital stay following metastatic brain tumor resection. Clin Exp Metastasis 2022; 39 (02) 303-310
• 12 Khalafallah AM, Huq S, Jimenez AE, Brem H, Mukherjee D. The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients. J Neurosurg 2020; 135 (01) 78-86
• 13 Shahrestani S, Lehrich BM, Tafreshi AR. et al. The role of frailty in geriatric cranial neurosurgery for primary central nervous system neoplasms. Neurosurg Focus 2020; 49 (04) E15
• 14 Bonney PA, Chartrain AG, Briggs RG. et al. Frailty is associated with in-hospital morbidity and nonroutine disposition in brain tumor patients undergoing craniotomy. World Neurosurg 2021; 146: e1045-e1053
• 15 Youngerman BE, Neugut AI, Yang J, Hershman DL, Wright JD, Bruce JN. The modified frailty index and 30-day adverse events in oncologic neurosurgery. J Neurooncol 2018; 136 (01) 197-206
• 16 Cohen ME, Liu Y, Ko CY, Hall BL. Improved surgical outcomes for ACS NSQIP hospitals over time: evaluation of hospital cohorts with up to 8 years of participation. Ann Surg 2016; 263 (02) 267-273